The adverse drug event collaborative: A joint venture to measure medication-related patient harm

New Zealand Medical Journal

Volumn 126, Issue 1368, 2013, Pages 9-20

  Seddon, Mary E ^a   Jackson, Aaron ^b   Cameron, Chris ^c   Young, Mary L ^d   Escott, Linda ^d   Maharaj, Ashika ^d   Miller, Nigel ^d  

^a Quality Improvement Unit   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

^c WELLINGTON HOSPITAL   (New Zealand)

^d CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; CODEINE; ENOXAPARIN; FENTANYL; FUROSEMIDE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; TRAMADOL;

AGE; ARTICLE; CHECKLIST; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG FATALITY; DRUG INDUCED DISEASE; GENDER; HUMAN; LENGTH OF STAY; MEDICATION ERROR; PATIENT ATTITUDE; PHARMACIST; PRACTICE GUIDELINE;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; CAUSALITY; CAUSE OF DEATH; COOPERATIVE BEHAVIOR; DISABILITY EVALUATION; FEMALE; HUMANS; LIFE SUPPORT CARE; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; NEW ZEALAND; PATIENT ADMISSION; PHARMACEUTICAL PREPARATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES;

EID: 84873500356     PISSN: 00288446     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274(1):29-34. Epub 1995/07/05.
2. Davis P, Lay-Yee R, Briant R, Ali W, Scott A, Schug S. Adverse events in New Zealand public hospitals I: occurrence and impact. N Z Med J. 2002;115(1167):U271. Epub 2003/01/29.
3. Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care. 2003;12(3):194-200. Epub 2003/06/07.
4. Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD. The Quality in Australian Health Care Study. Med J Aust. 1995;163(9):458-71. Epub 1995/11/06.
5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-5. Epub 1998/04/29.
6. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277(4):301-6. Epub 1997/01/22.
7. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997;277(4):307-11. Epub 1997/01/22.
8. Briant R, Ali W, Lay-Yee R, Davis P. Representative case series from public hospital admissions 1998 I: drug and related therapeutic adverse events. N Z Med J. 2004;117(1188):U747. Epub 2004/03/06.
9. Davis P, Lay-Yee R, Braint R, et al. Adverse Events in New Zealand Public Hospitals: Prinicple Findings From a National Survey. Wellington: Ministry of Health, 2001 December. Report No.: Contract No.: ISBN 0-478-26268-X (Internet).
10. Classen DC, Resar R, Griffin F, Federico F, Frankel T, Kimmel N, et al. 'Global trigger tool' shows that adverse events in hospitals may be ten times greater than previously measured. Health Aff (Millwood). 2011;30(4):581-9. Epub 2011/04/08.
11. Griffen F, Resar R. IHI Global Trigger Tool for Measuring Adverse Events. Cambridge, Massachusetts: Institute for Healthcare Improvement, 2007.
12. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140(10):795-801. Epub 2004/05/19.
13. National Coordinating Council for Medication Error Reporting and Prevention. What is a medication error? Rockville, MD: www. nccmerp.org; 1998 [cited 2011 1st November]; Available from: www. nccmerp.org.
14. Bates DW. Medication errors. How common are they and what can be done to prevent them? Drug Saf. 1996;15(5):303-10. Epub 1996/11/01.
15. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000;109(2):87-94. Epub 2000/09/01.
16. Hartwig SC, Denger SD, Schneider PJ. Severity-indexed, incident report-based medication error-reporting program. Am J Hosp Pharm. 1991;48(12):2611-6. Epub 1991/12/01.
17. Ministry of Health. Data and Statistics. Wellington: http://www.moh.govt.nz/moh.nsf/indexmh/dataandstatistics-subjects-surgvolsjun2011; 2011 [cited 2011 1st November].
18. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324(6):377-84. Epub 1991/02/07.
19. Franklin BD, Birch S, Schachter M, Barber N. Testing a trigger tool as a method of detecting harm from medication errors in a UK hospital: a pilot study. Int J Pharm Pract. 2010;18(5):305-11. Epub 2010/09/16.
20. Schildmeijer K, Nilsson L, Arestedt K, Perk J. Assessment of adverse events in medical care: lack of consistency between experienced teams using the global trigger tool. BMJ quality & safety. 2012;21(4):307-14. Epub 2012/03/01.
21. Kohn L. To err is human: an interview with the Institute of Medicine's Linda Kohn. Jt Comm J Qual Improv. 2000;26(4):227-34. Epub 2000/04/05.